Riskpilot← Back to searchSign inGet full accessBjörklinge Djurklinik AB
ABActiveOrg 5568276207Södra Långåsvägen 8Veterinary activities · NACE 7500Est. 20107 employees
Revenue 2025
SEK 6,8M
+6% vs 2024
EBITDA margin
2.7%
+1553% vs 2024
Equity ratio
16.2%
Financial strength
Net profit 2025
SEK 115K
+396% vs 2024
| Revenue | SEK 6,8M | +6% |
| EBITDA | SEK 182K | +1553% |
| Net profit | SEK 115K | +396% |
| Total assets | SEK 1,3M | +3% |
| Equity | SEK 215K | -14% |
| Employees | 7 | — |
Legal name
Björklinge Djurklinik AB
Org number
5568276207
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
25 november 2010
Share capital
SEK 100 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva veterinärpraktik samt annan därmed förenlig verksamhet.
Address
Södra Långåsvägen 8
Email
ekonomi@bjorklingedjurklinik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 486 | 5 459 | 6 208 | 6 443 | 6 800 |
| Staff expenses | — | −3 930 | −3 913 | −4 732 | −4 800 |
| EBITDA | 211 | −158 | 639 | −13 | 182 |
| Depreciation & amort. | −33 | −26 | −29 | −25 | −22 |
| EBIT | 178 | −184 | 609 | −37 | 159 |
| Net financials | −2 | −2 | −1 | 0 | −3 |
| Profit before tax | 176 | −185 | 608 | −37 | 156 |
| Tax | −28 | — | −98 | −2 | −41 |
| Net profit | 148 | −185 | 510 | −39 | 115 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 828 | 1 019 | 1 626 | 1 293 | 1 328 |
| Equity | 215 | 110 | 619 | 250 | 215 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 613 | 909 | 1 006 | 1 043 | 1 112 |
| Total debt | 613 | 909 | 1 006 | 1 043 | 1 112 |
EBITDA margin
2.7%
This company
15.8%
Market median
-83% vs market
20212025
Equity ratio
16.2%
This company
38.2%
Market median
-58% vs market
20212025
Return on equity
53.4%
This company
18.4%
Market median
+190% vs market
20212025
Net profit margin
1.7%
This company
8.1%
Market median
-79% vs market
20212025
Asset turnover
5.12×
This company
1.12×
Market median
+357% vs market
20212025
Debt / equity
5.17×
This company
0.62×
Market median
-734% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RP Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Björklinge Djurklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Patrik Spets | Audit | 0 companies |
| Per Rickard Lennart Bjerselius | Deputy Board Member | 0 companies |
| Ursula Susanne Nord Bjerselius | Chairman | 0 companies |
| Siri Katarina Adler Lennström | Board of Directors | 0 companies |
| Per Ola Nicklas Nord | Deputy Board Member | 0 companies |
| Finn Lennström | Deputy Board Member | 0 companies |